| 6740661 |
Farnesyl protein transferase inhibitors |
Arthur G. Taveras, Ronald J. Doll, Alan B. Cooper, Johan Ferreira, Timothy J. Guzi +11 more |
2004-05-25 |
$144,697,000 |
| 6528522 |
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
Neng-Yang Shih, Robert G. Aslanian, John J. Piwinski, Andrew T. Lupo, Jr. |
2003-03-04 |
$114,512,000 |
| 6440989 |
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
Joseph M. Kelly, Jay Weinstein, Ronald L. Wolin, Stuart B. Rosenblum |
2002-08-27 |
$151,480,000 |
| 6218401 |
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
Joseph M. Kelly, Jay Weinstein, Ronald L. Wolin, Stuart B. Rosenblum |
2001-04-17 |
$285,868,000 |
| 6214827 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
John J. Baldwin, Ronald J. Doll, Ge Li, Alan K. Mallams, F. George Njoroge +3 more |
2001-04-10 |
$295,894,000 |
| 6133291 |
N-(imidazolylalkyl)substituted cyclic amines as histamine-H.sub.3 agonists or antagonists |
Ronald L. Wolin, Stuart B. Rosenblum |
2000-10-17 |
$229,287,000 |
| 6130229 |
Tricyclic compounds having activity as RAS-FPT inhibitors |
Joseph M. Kelly, Stuart B. Rosenblum, Ronald L. Wolin, Jay Weinstein |
2000-10-10 |
$977,130,000 |
| 6124295 |
Compounds useful for inhibition of farnesyl protein transferase |
Arthur G. Taveras, Alan K. Mallams, Ronald J. Doll |
2000-09-26 |
$418,957,000 |
| 5985879 |
Compounds useful for inhibition of farnesyl protein transferase |
Arthur G. Taveras, Alan K. Mallams |
1999-11-16 |
$167,280,000 |
| 5958939 |
Tricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseases |
Joseph M. Kelly, Ronald L. Wolin |
1999-09-28 |
$80,448,000 |
| 5945429 |
Compounds useful for inhibition of farnesyl protein transferase |
Arthur G. Taveras, Alan K. Mallams, Ronald J. Doll |
1999-08-31 |
$150,223,000 |
| 5942522 |
Antiviral compounds and antihypertensive compounds |
Jay Weinstein, Margaret J. Gentles |
1999-08-24 |
$302,312,000 |
| 5891872 |
Tricyclic compounds |
Ronald J. Doll, Alan K. Mallams, Dinanath F. Rane, F. George Njoroge, Randall R. Rossman |
1999-04-06 |
$197,627,000 |
| 5880128 |
Carbonyl piperazinyl and piperidinyl compounds |
Ronald J. Doll, Alan K. Mallams, Dinanth F. Rane, George F. Njoroge, Randall R. Rossman +3 more |
1999-03-09 |
$283,133,000 |
| 5861395 |
Compounds useful for inhibition of farnesyl proteins transferase |
Arthur G. Taveras, Alan K. Mallams, Stacy Remiszewski, F. George Njoroge, Ronald J. Doll +2 more |
1999-01-19 |
$165,829,000 |
| 5801175 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
John J. Baldwin, Ronald J. Doll, Ge Li, Alan K. Mallams, F. George Njoroge +3 more |
1998-09-01 |
$454,196,000 |
| 5786480 |
4-substituted pyrazoloquinoline derivatives |
Joseph M. Kelly, Samuel Chackalamannil |
1998-07-28 |
$235,711,000 |
| 5712280 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Ronald J. Doll, Alan K. Mallams, Dinanath F. Rane, Randall R. Rossman, F. George Njoroge |
1998-01-27 |
$171,716,000 |
| 5703090 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Joseph M. Kelly, Ronald L. Wolin |
1997-12-30 |
$70,031,000 |
| 5684013 |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
Joseph M. Kelly, Ronald L. Wolin |
1997-11-04 |
$145,004,000 |
| 5672611 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Ronald J. Doll, Alan K. Mallams, Dinanath F. Rane, Randall R. Rossman, F. George Njoroge |
1997-09-30 |
$216,793,000 |
| 5608067 |
4-substituted pyrazoloquinoline derivatives |
Joseph M. Kelly, Samuel Chackalamannil |
1997-03-04 |
|
| 5597821 |
Pyrazoloquinolines |
Ronald L. Wolin |
1997-01-28 |
|
| 5595998 |
Pyrazoloquinolines |
Ronald L. Wolin, Joseph M. Kelly, F. George Njoroge |
1997-01-21 |
|
| 5506236 |
4-substituted pyrazoloquinoline derivatives |
Joseph M. Kelly, Samuel Chackalamannil |
1996-04-09 |
$96,731,000 |